Xarelto carries a significant risk of severe, uncontrolled internal bleeding. Read more
Trial is now underway in a New Orleans Federal Court in the first Xarelto bellwether trial. Read more
The ability to measure Xarelto’s effect on a patient’s blood can identify patients at high risk of bleeding. Read more
The lawyers in our Mass Torts Section will continue to review and file cases involving serious injuries or death related to Xarelto use. Read more
I mentioned the Xarelto litigation briefly, but more needs to be said on this litigation. Read more
Lawyers in our Mass Torts Section have been very busy. Read more
Among the hundreds of pending MDLs across the country, the report says some stand out for the huge jury awards returned against big companies. Read more
Xarelto is a blood thinner manufactured by German drug maker Bayer AG and distributed in the U.S. by Janssen Pharmaceuticals. Read more
If you need more information about the Xarelto litigation, contact David Byrne at 800-898-2034 or by email at David.Byrne@beasleyallen.com. Read more
It appears that drug manufacturers may have been submitting incomplete reports of side-affects to the FDA for a very long time. Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.